Completed and ongoing trials examining the role of GLP-1R agonists, especially semaglutide, in the treatment of glaucoma, AMD, Alzheimers, and Parkinsons disease, were searched on the public clinical trial registry clinicaltrials.gov ( NCT04777409, NCT04777396, NCT03811561, NCT01843075, NCT04232969, NCT03659682, NCT02953665, NCT04305002, NCT03439943, NCT04269642, NCT04154072, NCT02673931, NCT02829502, NCT02838589, NCT00418288, NCT00256256, NCT03948347, NCT03287076 , NCT02684578, NCT05035095 )
We have an IV for you
doi: 10.1210/endo-121-6-2112 26 ChehadeJKimJPinasJLMooradianAD
Furthermore, vital signs and adverse events (AEs) were observed
Metformin HCl No pharmacokinetic studies of metformin have been conducted in patients with hepatic impairment